Saudi Arabia

 

Diaverum deal: An analysis

Last week the news broke that Abu Dhabi sovereign wealth fund Mubadala Investment Co might be set to buy Swedish multinational dialysis firm Diaverum for a reported $2.5bn. HBI speaks to an operator source who thinks this would be a good price for the seller - and hears why some investors are switched off by dialysis.

Saudi boom creating billion dollar opportunities

Sources at the Arab Health exhibition confirm that the ambitious Saudi 2030 project which will see the country transfer most health care service delivery to the for-profit sector is still on. What are the implications of this?

Al Borg eyes franchising and reference markets

Big Saudi lab group Al Borg plans to use franchising to grow rapidly with a consumer-led offer which includes imaging and primary care. It is also constructing two enormous reference labs in Riyad and Jeddah with the aim of seizing a market where Saudi spends billions.  The group is also still eyeing a stock market listing.

Amanat to merge Sukoon and CMRC

Dubai-based listed health care and education investment firm Amanat Holdings is merging two of its post acute care providers in the GCC region, Sukoon and Cambridge Medical and Rehabilitation Center (CMRC), in the latest move in its plan to build the region's largest post-acute care platform.

Opportunities abound as Saudi Arabia plans $13bn private healthcare expansion

Saudi Arabia’s health ministry is making $13bn (SR48bn) plans for 100 healthcare projects that will involve the private sector. The public-private partnership proposals include constructing two new medical cities, a project to provide 900 beds for medical rehabilitation, and long-term care services, and it looks like foreign investors are actively being courted.

Saudi healthcare insurance boom

According to the Saudi Central Bank, gross healthcare insurance premiums in Saudi Arabia rose 32% to SR25.1 billion (€6.78 bn) between 2017 and 2021. Healthcare now totals as much as 59.7% of total insurance in the rich oil state.

HBI 2022: Balance of power in MENA is shifting

There is a risk, when looking at healthcare markets in MENA, of lumping all the countries together as one - but each market has very specific requirements, and very specific characteristics. A panel at HBI 2022 chaired by Hamid Yunis, partner at global law firm McDermott Will & Emery, investigated challenges and opportunities in the region - and how rapidly the markets are changing and why overseas players now need to work harder to impress.

Saudi Arabia backs new $400m hospital for Jordan

The University College London Medical School (UCLMS) is joining forces with the Saudi Jordanian Investment Fund (SJIF) and UCLA Health in a new $400 million (€380m) university hospital in Jordan.

Find Us